Speakers

Jeremy Abbate

Publisher

Scientific American

Lucy Abreu

Senior VP, Diversity, Equity and Inclusion Strategist and Employee Engagement Lead

Syneos Health Communications

Eric Aguiar

Partner

Aisling Capital LLC

Ram Aiyar

CEO

Korro Bio

Philippe Alen

Head of Cardiovascular Business Development Licensing & Alliance Management

Bayer SA-NV

Sujuan Ba

CEO

National Foundation for Cancer Research

Phyllis Barkman

Global Head, External Engagement, Alzheimer’s disease and Neurodegeneration

Eli Lilly & Company

Steve Bates

CEO

BioIndustry Association

Rubal Bedi

Global Head and VP of Corporate Venture Group

HOYA

Dawn Bell

Global Head, Strategic Partnerships

Novartis

Allyson Berent

CSO and COO

Foundation for Angelman Syndrome Therapeutics, GeneTx Biotherapeutics

Diane Berry

Senior VP, Global Health Policy, Government and Patient Affairs

Sarepta Therapeutics

Kate Bingham

Former Chair U.K. Vaccine Taskforce, Managing Partner

SV Health Managers LLP

Jeffrey Bockman

Executive VP and Oncology Practice Head

Cello Health BioConsulting

Ben Bonifant

Partner

Triangle Insights Group, LLC

Rick Bright

Former Director, Biomedical Advanced Research and Development Authority (BARDA), Transition Team

COVID-19 Advisory Board

P.J. Brooks

Program Director, Office of Rare Diseases Research

National Center for Advancing Translational Sciences (NCATS), NIH

Linda Brown

Advisory Board Member

New Jersey Bioscience Center Incubator

Stephen G. Brozak

Managing Partner and President

WBB Securities LLC

Terry-Ann Burrell

CFO

Beam Therapeutics

Gabriel P. Cavazos

Managing Director, Investment Banking

SVB Leerink

Tony Chen

Partner

Jones Day

Michael Chen, PhD

Head of Business Development

Akeso Biopharma, Inc.

Tak Cheung

Principal

New Enterprise Associates (NEA)

Grace Colon

CEO

InCarda Therapeutics Inc.

Paul Colvin

President, Clinical Solutions

Syneos Health

Jeff Cranmer

BioCentury Inc.

BioCentury Inc.

Donna Cryer

President and CEO

Global Liver Institute

Alice Valder Curran

Partner

Hogan Lovells

Marianne De Backer

Executive VP, Head of Strategy, Business Development & Licensing and Executive Committee Member

Bayer AG, Pharmaceuticals

Alaric DeArment

Reporter

Scrip

Sara Jane Demy

CEO and Founder

Demy-Colton

Rahul Dhanda

Co-Founder and CEO

Sherlock Biosciences

Steve Dickman

CEO

CBT Advisors

Ruxandra Draghia-Akli

Global Head

Johnson & Johnson Global Public Health R&D

Katherine Eban

Contributing Editor, Investigative Journalist, Author: Bottle of Lies: the Inside Story of the Generic Drug Boom

Vanity Fair

Bill Evans

CEO

Rock Health

Ming Fang, PhD

Head of Business Development

Elpiscience Biopharma

Melissa Fassbender

Former Journalist, Associate Director of External Communications

Polsky Center for Entrepreneurship & Innovation, University of Chicago

Sam Fazeli

Director of EMEA Research and Senior Pharmaceutical Analyst, BI

Bloomberg L.P.

Hill Ferguson

CEO

DoctorOnDemand

Prabhavathi Fernandes

Chair

National Biodefense Science Board

Amy Finan

CEO

Sabin Vaccine Institute

Andrew Fish

CSO

AdvaMed

Stephen Flaim

Senior Special Advisor and Investor-in-Residence

National Institutes of Health

Mani Foroohar

Managing Director and Senior Research Analyst

SVB Leerink

Maria Fotiu

Executive VP of Decentralized Solutions

Syneos Health

Kyle Gano

Chief Business Development and Strategy Officer

Neurocrine Biosciences (NASDAQ: NBIX)

Cathy Gao

VP

Sapphire Venture

Julie Gerberding

Executive VP and Chief Patient Officer

Merck & Co. Inc.

Harry Glorikian

General Partner

Scientia Ventures

Jennifer Friel Goldstein

Managing Partner, Life Science and Healthcare

SVB Capital

Mara Goldstein

Managing Director

Mizuho Securities USA

Marc Goodman

Managing Director

SVB Leerink Equity Research, Neuroscience

Asthika Goonewardene

Managing Director and Senior Analyst

Truist Securities

Arjun Goyal

Co-Founder and Managing Director

Vida Ventures

Shaun Grady

Senior VP of Business Development Operations

AstraZeneca

Frank Grams, PhD

SVP Alliance Management and Head BD Europe

Everest Medicines

Dave Greenwald

VP

Deerfield Management

Nicole Guadelli

Director and Head of Gene Editing Technologies

Beam Therapeutics

Geneviève Guertin

VP Investment, Life Sciences

Fonds de solidarité FTQ

Adele Gulfo

CBO and Commercial Development Officer

Sumitovant Biopharma

Moira Gunn

Host of Tech Nation and Professor

NPR, University of San Francisco

Taylor Guo

Co-Founder and CSO

I-Mab Biopharma

Kimberly Ha

CEO and Founder

KKH Advisors

Ted Haack

VP

Lattice Point Consulting

Leslie Haas

Manager of Digital Health Strategy

Stanford Health Care

Katya Hancock

Investment Network Director

StartUp Health

Dan Hanfling

VP

In-Q-Tel

Katherine Harris

Associate

Silicon Valley Bank

Paul J. Hastings

President and CEO

Nkarta Therapeutics, Inc. (NASDAQ GS: NKTX)

Richard Hatchett

CEO

CEPI

Rachel Haurwitz

President and CEO

Caribou Biosciences, Inc.

Jeff Hawkins

CEO

Truvian Health

Kathy He

CBO

Kira Pharmaceuticals

Kathy He

CBO

Kira Pharmaceuticals

Deepak Hegde

Associate Professor of Management and Organizations and Director

Endless Frontier Labs, New York University, Stern School of Business

Abraham Heifets

Co-Founder and CEO

Atomwise

Jaime E. Hernandez

Executive Medical Director, Infectious Disease and Vaccines

Syneos Health

Berthold Hinzen

VP and Head of Business Development and Licensing, Therapeutic Areas

Bayer AG

Beth Hoffman

Founder and CEO

Origami Therapeutics, Inc.

Alison Holland

Head of Decentralized and Remote Trials

Medable

Rich Horgan

Founder

Cure Rare Disease

Peyton Howell

Executive VP, CCO and CSO

Parexel

Betty Huang

Head of Business Development and Licensing for China/APAC

Bayer AG

Joan Huaqiong Shen, M.D., Ph.D.

CEO

I-Mab Biopharma

James Hury

CIO

Translational Research Institute for Space Health

Rachelle Jacques

CEO

Enzyvant

Alyssa Jaffee

Partner

7wireVentures

Sarah Jenna

Co-Founder and CEO

Montreal Institute of Learning Algorythms

Darren Ji

Chairman and CEO

Elpiscience

Fang Jianmin, Ph.D.

Founder and CEO

RemeGen

Ben Johnson

Head of Early Stage Life Science

Silicon Valley Bank

Sari Kaganoff

General Manager of Consulting

Rock Health

Armen Kherlopian

Co-Founder

BAJ Accelerator

David J. Kim

Managing Director

DigiTx Partners

Nina Kjellson

General Partner

Canaan

Arthur Klausner

President and CEO

Goldilocks Therapeutics, Inc.

Jak Knowles

CBO

Metagenomi

William Kolb

Partner

Foley Hoag

Peter Kolchinsky

Founder and Managing Partner

RA Capital Management

Walt Kowtoniuk

Partner

Third Rock

Michael Kurilla

Director of Division of Clinical Innovation

National Center for Advancing Translational Sciences, National Institutes of Health

Janet Lambert

CEO

Alliance for Regenerative Medicine

Tomas Landh

Innovation Sourcing VP, Senior Principal Scientist

Novo Nordisk

Leanne Larson

Senior VP, Real-World Evidence & Access

Parexel

Jon Layman

Partner

Hogan Lovells

Douglas Lee

VP, Business Development & Licensing Head Digital & Data Science

Bayer U.S. Pharmaceuticals

Nick Leschly

Chief Bluebird

bluebird bio

Taja Lester

Managing Partner

Health Equity Capital

Jeremy Levin

CEO, Ovid Therapeutics; Board of Directors Chair

Biotechnology Innovation Organization (BIO)

Julia Levy

Founder and Former CEO

QLT Inc.

Virginia Li

Associate Editor

BioCentury

James Li, M.D.

Co-Founder and CEO

JW Therapeutics

Craig Lipset

Managing Partner

Clinical Innovation Partners LLC

Will Liu, PhD

Partner

Eight Roads Ventures

Brad Loncar

CEO

Loncar Investments

Michelle Longmire

Founder and CEO

Medable

Philippe Lopes-Fernandes

Executive VP and CBO

Ipsen

Stephanie Léouzon

Partner and Head

Torreya Europe

Geoff MacKay

CEO

AVROBIO (NASDAQ: AVRO)

Sandy Macrae

President & CEO

Sangamo Therapeutics

Gail Maderis

President and CEO

Antiva Biosciences

Sean Marett

CBO and CCO

BioNtech (NASDAQ: BNTX)

Peter Marks

Director of Center for Biologics Evaluation and Research

U.S. Food and Drug Administration

Craig Martin

CEO

Global Genes

Lisa Mazur

Partner

McDermott Will & Emery

John McDonald

Corporate VP and Global Head Business Development

Novo Nordisk

Michelle McMurry-Heath

President and CEO

Biotechnology Innovation Organization (BIO)

Sheila A. Mikhail

Co-Founder and CEO

Asklepios BioPharmaceutical, Inc. (AskBio)

Ken Mills

President and CEO

REGENXBIO

Angeli Moeller

Appointed Head of Pharma Informatics International

Roche

Juliet Moritz

COO

Illingworth Research

Dylan Morris

General Partner

CRV

Christopher Mortko

Associate VP

Merck & Co Inc.

Aziz Mottiwala

CCO

Tarsus Pharmaceuticals

Bibhash Mukhopadhyay

Principal

New Enterprise Associates (NEA)

Naveen Murthy

Senior Managing Director and Head of Product & Franchise Strategy, Commercial Advisory Group, Consulting

Syneos Health

Matthias Müllenbeck

Executive Director & Head Global Licensing and Business Development Enabling Technologies Biopharma, Global Business Development and Alliance Management

Merck KGaA, Darmstadt, Germany

Marian T. Nakada

VP Venture Investments

Johnson & Johnson Innovation, JJDC

Robert Narquizian

Managing Director

ChinaBio® Group

Sara Nayeem

Partner

NEA

Kimberly Nearing

Venture Partner

BVCF

Art Pappas

Managing Partner

Pappas Capital

Jean-Francois Pariseau

Co-Founder and Partner

Amplitude Ventures

Chen Partner

Partner

Jones Day

Bakul Patel

Director of Digital Health Center of Excellence

Food and Drug Administration

Joseph Payne

President and CEO

Arcturus Therapeutics, Inc.

Joseph Payne

President and CEO

Arcturus Therapeutics (NASDAQ: ARCT)

Danielle Peters

President

Magnet Strategy Group Cross-Border Health Foundation

Valérie Pisano

President and CEO

Mila Research Institute

Logan Plaster

Director and Editor-in-Chief

StartUp Health

Scott Platshon

Principal

EcoR1 Capital

Vernessa Pollard

Partner and Chair

McDermott Will & Emery, FDA Practice

Dennis J. Purcell

Founder and Senior Advisor

Aisling Capital

Sachin Purwar

Director of Commercial Advisory Group, Consulting

Syneos Health

Yasmeen Rahimi

Senior Research Analyst

Piper Sandler

Adrian Rawcliffe

CEO

Adaptimmune

Madeline Repollet

Head of Clinical Laboratories

ANGLE plc

Bryan Roberts

Partner

Venrock

Scot Roberts

CSO

Altimmune (NASDAQ: ALT)

Robin Robinson

CSO and Founding Director

RenovaCare, BARDA

Liz Rockett

Managing Director

Kaiser Permanente Ventures

Beth Rogozinski

CEO

Oncoustics

Leah Rosenbaum

Assistant Editor, Healthcare & Science

Forbes

Renee Ryan

CEO

Cala Health

Una S. Ryan

Managing Director

Golden Seeds

Sony Salzman

Coordinating Producer, Medical Unit

ABC

Camille Samuels

Partner

Venrock

Vijay Sappani

Founder and CEO

Ela Capital, CDG Canada

Michael Sarshad

Director of Commercial Advisory Group, Consulting

Syneos Health

Tracy Saxton

Managing Director

Dolby Family Ventures

Andrew Schachter

Founder and CEO

Axiom Real-Time Metrics

Danielle Schlosser

Head and Behavioral Health Lead

Verily Life Sciences, an Alphabet Company

Robert J. Schneider

Albert Sabin Professor of Molecular Pathogenesis

NYU School of Medicine, Alexandria Center for Life Sciences

Robert J. Schneider

Albert Sabin Professor of Molecular Pathogenesis

NYU School of Medicine, Alexandria Center for Life Sciences

Joanna Schulman

CEO

AIDIA Collective

Greg Scott

Founder and Chairman

ChinaBio® Group

Jodi Scott

Partner

Hogan Lovells US LLP

Laura Shawver

CEO

Silverback Therapeutics (NASDAQ: SBTX)

Tom Shebab

Managing Partner

Arboretum Ventures

Greg Simon

Consultant

Simonovation LLC

Ajit Singh

Partner

Artiman Ventures

Moncef Slaoui

Scientific Head

Operation Warp Speed

Debora Spar

Professor and Senior Associate Dean

Harvard Business School

Kumar Srinivasan

VP and Global Head of Business Development and Licensing, BioPharmaceuticals R&D

AstraZeneca Pharmaceuticals

Laura Stoppel

Principal

RA Capital Management

Anthony Sun

CEO

Zentalis Pharmaceuticals (NASDAQ: ZNTL)

Amy Tang

Venture Partner

Qiming Venture Partners.

Solome Tibebu

Founder

Going Digital: Behavioral Health Tech

Victor E. Tong, Jr.

Partner

Decheng Capital

Rafaèle Tordjman

Founder and CEO

Jeito Capital

John J. Trizzino

Executive VP, CCO and CBO

Novavax

Christian Tucat

President, Syneos One and Real World Evidence

Syneos Health

Vicki Vakiener

CCO

Epizyme

John Vandermosten

Senior Biotechnology Analyst

Zacks Small Cap Research

Vangelis Vergetis

CEO

Intelligencia Inc.

Laura Veroneau

Partner

Optum Ventures

Dhruv Vig

VP

Silicon Valley Bank

Chris Wasden

Head of HappifyDTx

Happify Health

Michelle Xia

President and CEO

Akesobio

Stella Xu

Managing Director

Quan Capital

Brian Yang

Senior Editor, China Head

Informa Business Intelligence

Jingwu Zang

Founder and Honorary Chairman

I-Mab Biopharma (NASDAQ: IMAB)

Alex Zhang, PhD

CEO

Hanhai Silicon Valley

PC Zhu, Ph.D

Founder and CEO

ATLATL Innovation Center

Meg Zweig

COO

Rock Health